Cargando…

Neutralizing immunity in vaccine breakthrough infections from the SARS-CoV-2 Omicron and Delta variants

Virus-like particle (VLP) and live virus assays were used to investigate neutralizing immunity against Delta and Omicron SARS-CoV-2 variants in 259 samples from 128 vaccinated individuals. Following Delta breakthrough infection, titers against WT rose 57-fold and 3.1-fold compared with uninfected bo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Servellita, Venice, Syed, Abdullah M., Morris, Mary Kate, Brazer, Noah, Saldhi, Prachi, Garcia-Knight, Miguel, Sreekumar, Bharath, Khalid, Mir M., Ciling, Alison, Chen, Pei-Yi, Kumar, G. Renuka, Gliwa, Amelia S., Nguyen, Jenny, Sotomayor-Gonzalez, Alicia, Zhang, Yueyuan, Frias, Edwin, Prostko, John, Hackett, John, Andino, Raul, Wadford, Debra A., Hanson, Carl, Doudna, Jennifer, Ott, Melanie, Chiu, Charles Y.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Inc. 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8930394/ https://www.ncbi.nlm.nih.gov/pubmed/35429436 http://dx.doi.org/10.1016/j.cell.2022.03.019

Ejemplares similares

Limited cross-variant immunity from SARS-CoV-2 Omicron without vaccination
por: Suryawanshi, Rahul K., et al.
Publicado: (2022)

Previous exposure to Spike-providing parental strains confers neutralizing immunity to XBB lineage and other SARS-CoV-2 recombinants in the context of vaccination
por: Suryawanshi, Rahul K., et al.
Publicado: (2023)

Omicron mutations enhance infectivity and reduce antibody neutralization of SARS-CoV-2 virus-like particles
por: Syed, Abdullah M., et al.
Publicado: (2022)

Omicron mutations enhance infectivity and reduce antibody neutralization of SARS-CoV-2 virus-like particles
por: Syed, Abdullah M., et al.
Publicado: (2022)

Nucleic acid biomarkers of immune response and cell and tissue damage in children with COVID-19 and MIS-C
por: Loy, Conor J., et al.
Publicado: (2023)

Rapid assembly of SARS-CoV-2 genomes reveals attenuation of the Omicron BA.1 variant through NSP6
por: Taha, Taha Y., et al.
Publicado: (2023)

Rapid assessment of SARS-CoV-2–evolved variants using virus-like particles
por: Syed, Abdullah M., et al.
Publicado: (2021)

COVID-19 Variant Detection with a High-Fidelity CRISPR-Cas12 Enzyme
por: Fasching, Clare L., et al.
Publicado: (2022)

Omicron breakthrough infections in vaccinated or previously infected hamsters
por: Zhou, Jie, et al.
Publicado: (2023)

Transmission, infectivity, and antibody neutralization of an emerging SARS-CoV-2 variant in California carrying a L452R spike protein mutation
por: Deng, Xianding, et al.
Publicado: (2021)

Transmission, infectivity, and neutralization of a spike L452R SARS-CoV-2 variant
por: Deng, Xianding, et al.
Publicado: (2021)

Omicron BQ.1 and BQ.1.1 escape neutralisation by omicron subvariant breakthrough infection
por: Jiang, Xiao-Lin, et al.
Publicado: (2023)

Potent cross-reactive antibodies following Omicron breakthrough in vaccinees
por: Nutalai, Rungtiwa, et al.
Publicado: (2022)

Omicron breakthrough infections in patients with immune-mediated inflammatory diseases
por: Liew, Jean W, et al.
Publicado: (2022)

1467. Breakthrough Omicron Infections in Booster Vaccinated Healthcare Workers
por: Lee, Jeongjae, et al.
Publicado: (2022)

SARS-CoV-2 Anti-Spike IgG Antibody and ACE2 Receptor Binding Inhibition Levels among Breakthrough Stage Veteran Patients
por: Chensue, Stephen W., et al.
Publicado: (2022)

Antibody titers and breakthrough infections with Omicron SARS-CoV-2
por: Dimeglio, Chloé, et al.
Publicado: (2022)

Evolution of antibody immunity following Omicron BA.1 breakthrough infection
por: Kaku, Chengzi I., et al.
Publicado: (2022)

Durability of neutralization against Omicron subvariants after vaccination and breakthrough infection
por: Zhu, Ka-Li, et al.
Publicado: (2023)

Durable reprogramming of neutralizing antibody responses following Omicron breakthrough infection
por: Lee, Wen Shi, et al.
Publicado: (2023)

Evolution of antibody immunity following Omicron BA.1 breakthrough infection
por: Kaku, Chengzi I., et al.
Publicado: (2023)

Immune responses in Omicron SARS-CoV-2 breakthrough infection in vaccinated adults
por: Kared, Hassen, et al.
Publicado: (2022)

Awareness of SARS-CoV-2 Omicron Variant Infection Among Adults With Recent COVID-19 Seropositivity
por: Joung, Sandy Y., et al.
Publicado: (2022)

Omicron (B.1.1.529): Infectivity, vaccine breakthrough, and antibody resistance
por: Chen, Jiahui, et al.
Publicado: (2021)

Omicron neutralizing antibody response following booster vaccination compared with breakthrough infection
por: Curlin, Marcel E., et al.
Publicado: (2022)

Omicron neutralizing antibody response following booster vaccination compared with breakthrough infection
por: Curlin, Marcel E., et al.
Publicado: (2022)

Breakthrough omicron COVID-19 infections in patients receiving the REGEN-Cov antibody combination
por: Flahault, Adrien, et al.
Publicado: (2022)

Individuals With Weaker Antibody Responses After Booster Immunization Are Prone to Omicron Breakthrough Infections
por: Möhlendick, Birte, et al.
Publicado: (2022)

Infectiousness of SARS-CoV-2 breakthrough infections and reinfections during the Omicron wave
por: Tan, Sophia T., et al.
Publicado: (2022)

Protection Against Breakthrough Delta/Omicron Variants in Vaccinated Patients with Myeloproliferative Neoplasms (MPN)
por: Barbui, Tiziano, et al.
Publicado: (2022)

Correlation of Breakthrough Infection During the Omicron Wave With Seropositivity of Vaccinated Patients Undergoing Hemodialysis
por: Patnaik, Aswini P, et al.
Publicado: (2022)

Taking cues from convalescence to improve vaccines against hepatitis C virus
por: Sreekumar, Bharath K., et al.
Publicado: (2022)

CRISPR-Cas12–based detection of SARS-CoV-2
por: Broughton, James P., et al.
Publicado: (2020)

Post-acute immunological and behavioral sequelae in mice after Omicron infection
por: Ma, Tongcui, et al.
Publicado: (2023)

Emergence of Omicron BA.1 and BA.2 variants and concern over vaccine breakthrough infection
por: Sukaina, Mahnoor, et al.
Publicado: (2022)

Low neutralisation of the omicron BA.2 sublineage in boosted individuals who had breakthrough infections
por: Karaba, Andrew H, et al.
Publicado: (2022)

SARS-CoV-2 Vaccine Breakthrough by Omicron and Delta Variants, New York, USA
por: Keyel, Alexander C., et al.
Publicado: (2022)

Breakthrough infection shapes humoral immunity against SARS-CoV-2 Omicron Variant
por: Zhang, Yuwei, et al.
Publicado: (2023)

Correlates of protection and viral load trajectories in omicron breakthrough infections in triple vaccinated healthcare workers
por: Marking, Ulrika, et al.
Publicado: (2023)

SARS-CoV-2 vaccine-induced antibodies protect against Omicron breakthrough infection
por: Baerends, Eva A.M., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_5s7es4ar7k83ab4g0c90njsaha